Sunshine Biopharma (SBFM) Operating Leases (2019 - 2026)
Sunshine Biopharma's (SBFM) quarterly Operating Leases came in at $535614.0 in Q1 2026, down 25.84% YoY from $722199.0 in Q1 2025, and down 10.25% on a QoQ basis from $596785.0 in Q4 2025.
Sunshine Biopharma (SBFM) Operating Leases (2019 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 6 years of Operating Leases data on file, last reported at $535614.0 in Q1 2026.
- Quarterly Operating Leases fell 25.84% year-over-year to $535614.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $535614.0 (down 25.84% YoY) and the FY2025 annual result came in at $596785.0, down 19.86% from the prior year.
- Operating Leases fell to $535614.0 in Q1 2026, from $596785.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $744724.0 in Q4 2024 to a low of $440298.0 in Q3 2024.
- A 5-year average of $592119.4 and a median of $596817.5 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2025 — Operating Leases jumped 52.63% — and 2026, when it fell 25.84%.
- Tracing SBFM's Operating Leases over 5 years: stood at $642232.0 in 2022, then retreated by 16.07% to $539035.0 in 2023, then jumped by 38.16% to $744724.0 in 2024, then slipped by 19.86% to $596785.0 in 2025, then retreated by 10.25% to $535614.0 in 2026.
- The last three Operating Leases figures came in at $535614.0 (Q1 2026), $596785.0 (Q4 2025), and $636708.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 475,820.00 |
| Mar 31, 2026 | 535,614.00 |
| Dec 31, 2025 | 596,785.00 |
| Sep 30, 2025 | 636,708.00 |
| Jun 30, 2025 | 706,530.00 |
| Mar 31, 2025 | 722,199.00 |
| Dec 31, 2024 | 744,724.00 |
| Sep 30, 2024 | 440,298.00 |
| Jun 30, 2024 | 462,906.00 |
| Mar 31, 2024 | 496,968.00 |
| Dec 31, 2023 | 539,035.00 |
| Sep 30, 2023 | 555,687.00 |
| Jun 30, 2023 | 596,850.00 |
| Mar 31, 2023 | 613,136.00 |
| Dec 31, 2022 | 642,232.00 |
| Mar 31, 2019 | 49,148.00 |